EDIT vs TECX: stock comparison and AI forecast
Editas Medicine, Inc. (EDIT) and Tectonic Therapeutic, Inc. (TECX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
EDIT Editas Medicine, Inc.
- Market Cap
- $392M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
TECX Tectonic Therapeutic, Inc.
- Market Cap
- $380M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- EDIT and TECX have similar market capitalizations ($392M and $380M).
- EDIT carries 1.25 times debt per unit of equity, against 0.06 times for TECX.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | EDIT | TECX |
|---|---|---|
| Market Cap | $392M | $380M |
| P/B Ratio | 3.72x | 1.66x |
| EPS | $-1.32 | $-5.56 |
| Book Value/Share | $0.69 | $11.73 |
| Revenue/Share | $0.29 | – |
| FCF/Share | $-0.78 | $-3.55 |
Profitability & Margins
| Metric | EDIT | TECX |
|---|---|---|
| ROE | – | -38.4% |
| ROA | – | -36.1% |
| ROIC | -44.9% | -41.6% |
| Operating Margin | -171.7% | – |
| EBT Margin | -171.7% | – |
| Tax Rate | – | -0.4% |
Financial Health
| Metric | EDIT | TECX |
|---|---|---|
| Current Ratio | 3.19x | 19.71x |
| D/E Ratio | 1.25x | 0.06x |
| Financial Leverage | 2.25x | 1.06x |
| Interest Coverage | -17.5x | 1728.7x |
| Working Capital | $150M | $226M |
Cash Flow
| Metric | EDIT | TECX |
|---|---|---|
| Operating Cash Flow | -$120M | -$69M |
| Free Cash Flow | -$121M | -$69M |
| Capital Spending | -$690K | -$100K |
| FCF/Sales | -272.9% | – |
| CapEx/Sales | 1.6% | – |
Operational Efficiency
| Metric | EDIT | TECX |
|---|---|---|
| Asset Turnover | 0.19x | – |
| Receivables Turnover | 16.2x | – |
| Fixed Assets Turnover | 17.2x | – |
| Days Sales Outstanding | 23 days | – |
| Payables Period | – | -4 days |
Income Statement
| Metric | EDIT | TECX |
|---|---|---|
| Total Revenue | $44M | – |
| Operating Income | -$76M | -$96M |
| Net Income | – | -$88M |
| R&D Expense | $85M | $73M |
| Cost of Goods Sold | – | -$152M |
Dividend & Shareholder Information
| Metric | EDIT | TECX |
|---|---|---|
| Shares Outstanding | 154M | 20M |
EDIT vs TECX: stock comparison and AI forecast
Which is bigger, EDIT or TECX?
EDIT and TECX have similar market capitalizations ($392M and $380M).
Which one does Intratio's AI model rank higher, EDIT or TECX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.